LP
DXCM icon

Longaeva Partners’s DexCom DXCM Stock Holding History

Longaeva Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
14,973
-120,027
-89% -$8M 0.02% 297
2026
Q1 		$8.48M Buy
+135,000
New +$9.4M 0.31% 78

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Longaeva Partners's DXCM Position: Q2 2026 in Review

Longaeva Partners reduced its DexCom (DXCM) stake by 89% in Q2 2026, selling an estimated $8M and leaving 14,973 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #297.

Longaeva Partners first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.48M in Q1 2026. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Longaeva Partners held 14,973 shares of DexCom worth $1.01M as of Q2 2026.
  • Longaeva Partners sold 120,027 DexCom shares in Q2 2026, an estimated $8M.
  • DexCom made up 0.02% of Longaeva Partners's portfolio in Q2 2026, its #297 holding.
  • Longaeva Partners first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • Longaeva Partners's DexCom position peaked at $8.48M in Q1 2026.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.